Concepedia

Publication | Open Access

Ibrutinib Plus Venetoclax for First-line Treatment of Chronic Lymphocytic Leukemia

108

Citations

18

References

2021

Year

Abstract

ClinicalTrials.gov Identifier: NCT02756897.

References

YearCitations

Page 1